Literature DB >> 6261925

Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of a case.

E V Braun, M Ali, A O Fayemi, E Beaugard.   

Abstract

A case of primary signet-ring carcinoma of the urinary bladder treated with total cystectomy and clinically disease-free three years and nine months after surgery is described. The signet-ring cell carcinoma of the bladder is a rare neoplasm; among the five cases found in the literature, the neoplasms pursued a fulminant course, diffusely invaded the bladder wall without forming intraluminal growths, and could not be controlled by segmental resection, radiotherapy, and chemotherapy alone or in combinations. The pathogenesis of mucus-producing signet-ring cell carcinoma in the urinary bladder, an organ that normally contains no mucogenic elements, is discussed. The histologic evidence for the origin of this neoplasm from the totipotent urothelium is illustrated.

Entities:  

Mesh:

Year:  1981        PMID: 6261925     DOI: 10.1002/1097-0142(19810315)47:6<1430::aid-cncr2820470631>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Increased frequency and nocturia in a middle aged male may not always be due to benign prostatic hypertrophy: a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-09-15

2.  Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-10-27

3.  A case report of primary upper urinary tract signet-ring cell carcinoma and literature review.

Authors:  Zhaohua Ye; Qiwu Mi; Daosheng Luo; Zhixiong Li; Jiexin Luo
Journal:  BMC Urol       Date:  2020-06-26       Impact factor: 2.264

4.  Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy.

Authors:  Takashi Hamakawa; Yoshiyuki Kojima; Taku Naiki; Yasue Kubota; Takahiro Yasui; Keiichi Tozawa; Yutaro Hayashi; Kenjiro Kohri
Journal:  Case Rep Urol       Date:  2013-05-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.